scFv antibodies in the used tetravalent bispecific (scFv1-linker-hIgG1-Fc-StrepTag-scFv2)2 format recognized tumor-associated antigens with the N-terminal scFv1 and either CD3ε or CD28 receptors with the C-terminal scFv2 (26). Here, CD3E is linked to neoplasm.